Creative Biolabs supports microbiome innovators who need credible, strain-resolved evidence—not generic “probiotic claims.” For Lactobacillus paracasei, we deliver end-to-end R&D support spanning strain discovery, identity confirmation, functional validation, host-interaction assessment, and manufacturability-focused development—so your program moves from concept to decision-ready data with speed and scientific rigor.
Built for teams that need reproducible, audit-ready L. paracasei data across discovery, development, and scale-up.
L. paracasei sits in a taxonomically complex group (often discussed under Lacticaseibacillus reclassification), and strain-level differences can radically change performance in stress tolerance, adhesion, metabolite output, and safety profiles. A CRO workflow that treats “species name = function” creates avoidable risk—especially when you approach downstream manufacturing, claims substantiation, and stability targets.
A dedicated service track solves the real bottlenecks: rapid isolation of high-potential L. paracasei candidates, confident identity and purity confirmation, mechanistic screening that produces interpretable readouts, and manufacturing-aligned optimization (fermentation + formulation + stability) to protect viability and functionality through processing and shelf-life.
For L. paracasei, we isolate target strains from traditional fermented foods (e.g., yogurt, cheese) and/or human gut-derived samples using selective workflows, then run high-throughput screening for acid tolerance, bile tolerance, and other performance-linked traits to shortlist strains with real commercial potential.
We confirm whether your isolate is truly L. paracasei using a layered identity strategy—16S rRNA sequencing, whole-genome sequencing (WGS), and biochemical profiling—then map phylogeny and relatedness to ensure traceable genetic background, clean lineage, and defensible strain documentation.
We evaluate L. paracasei functional signatures including lactic acid production, antimicrobial activity (including bacteriocin-associated effects), antioxidant capacity, and epithelial adhesion potential. The goal is to translate “good growth” into measurable function and early mechanistic hypotheses you can test, prioritize, and refine.
To clarify how L. paracasei behaves in host-relevant systems, we assess barrier-associated readouts, immune signaling modulation profiles, and metabolism-linked markers in controlled in vitro or ex vivo setups—designed to generate interpretable evidence of interaction patterns rather than broad, non-specific claims.
We improve L. paracasei performance through adaptive evolution and/or metabolic engineering approaches aimed at practical outcomes—higher thermal/acid robustness, improved process survivability, or enhanced production of defined metabolites—so the strain is better aligned with real industrial constraints.
We develop and optimize high-density fermentation for L. paracasei by tuning media composition (carbon/nitrogen sources) and process parameters (pH, temperature, feed strategy). The deliverable is manufacturing-relevant biomass yield and activity retention—supported by structured process data.
Because L. paracasei can be sensitive to oxygen, heat, and dehydration stress, we design formulation strategies such as microencapsulation and freeze-drying with protective excipient systems to preserve viability and functional performance through processing, storage, and downstream application needs.
We run long-term, accelerated, and real-time stability programs to track L. paracasei viable counts across temperature and humidity conditions. Outputs include shelf-life trend data, critical degradation drivers, and quality-stability risk flags—useful for product development decisions and documentation.
Define L. paracasei success metrics, strain targets, and intended application constraints.
Generate a diverse L. paracasei isolate library from selected sources.
Confirm L. paracasei identity via sequencing and contamination controls.
Quantify key L. paracasei phenotypes using decision-oriented assays.
Optimize L. paracasei fermentation, formulation, and survivability parameters.
Deliver stability curves and a structured L. paracasei technical dossier.
Decisions built on verified L. paracasei identity, not assumptions.
Screens that anticipate scale, formulation stress, and shelf-life realities early.
Functional endpoints designed to support hypothesis-driven MoA iteration.
Traceable methods, strain records, and data organization for smoother reviews.
Modular builds to match your timeline, budget, and technical risk profile.
From discovery through stability, one coordinated CRO pathway.
Specific L. paracasei strains have been investigated in controlled human studies for allergic rhinitis–related quality-of-life endpoints, supporting continued interest in immune response modulation research designs.
In randomized studies, L. paracasei–containing regimens have been evaluated for GI symptom-related outcomes, motivating further strain-specific work on barrier function, microbial ecosystem shifts, and dose-response optimization.
L. paracasei is frequently profiled in immune-focused screening—using cytokine panels and host-interaction assays—to characterize how strains may influence inflammatory signaling patterns under defined experimental conditions.
L. paracasei is widely used in fermented food development (especially dairy), where performance targets include acidification kinetics, sensory contribution, and survivability—making strain selection and process optimization central to product R&D.
Certain L. paracasei interventions have been studied for lipid-panel shifts and related biomarkers, supporting ongoing interest in bile-salt metabolism pathways and BSH-linked screening strategies in controlled research settings.
Strain-specific L. paracasei research includes antioxidant capacity evaluation and human performance-related endpoints, reinforcing the need for rigorous phenotyping, stability control, and reproducible formulation designs.
Explore our diverse L. paracasei products, covering strains, genomic DNA, and postbiotics.
| Product Name | Catalog No. | Target | Product Overview | Size | Price |
|---|---|---|---|---|---|
| Lactobacillus paracasei Powder | LBP-005FG | Lactobacillus | Freeze-dried Lactobacillus paracasei Powder | — | Inquiry |
| Lactobacillus paracasei; 192210 | LBST-149FG | Lactobacillus | Lactobacillus paracasei was isolated from fermented yak milk. It is a Gram-positive, homofermentative species of lactic acid bacteria that are commonly used in dairy product fermentation and as probiotic cultures. | 200 µg | $1,380.00 |
| Lactobacillus paracasei; 354789 | LBST-150FG | Lactobacillus | Lactobacillus paracasei is a Gram-positive, homofermentative species of lactic acid bacteria that are commonly used in dairy product fermentation and as probiotic cultures. | 200 µg | $1,460.00 |
| Lactobacillus paracasei ; 24719 | LBGF-0722-GF67 | Lactobacillus | Lactobacillus paracasei ; 24719 has proven effective in preventing chronic stress-associated behaviors from developing in two recent pre-clinical experiments of the same model. | 200 µg | $1,590.00 |
| Lactobacillus paracasei subsp. paracasei; 8132 | LBGF-0722-GF86 | Lactobacillus | Lactobacillus paracasei subsp. paracasei is a Gram-positive, homofermentative species of lactic acid bacteria that are commonly used in dairy product fermentation and as probiotic cultures. | 200 µg | $980.00 |
| Lactobacillus paracasei subsp. paracasei; 8130 | LBGF-0722-GF87 | Lactobacillus | Lactobacillus paracasei subsp. paracasei is a Gram-positive, homofermentative species of lactic acid bacteria that are commonly used in dairy product fermentation and as probiotic cultures. | 200 µg | $980.00 |
| Lactobacillus paracasei subsp. paracasei; 2769 | LBGF-0722-GF88 | Lactobacillus | Lactobacillus paracasei subsp. paracasei is a Gram-positive, homofermentative species of lactic acid bacteria that are commonly used in dairy product fermentation and as probiotic cultures. | 200 µg | $980.00 |
| Lactobacillus paracasei subsp. paracasei; 1109 | LBGF-0722-GF89 | Lactobacillus | Lactobacillus paracasei subsp. paracasei is a Gram-positive, homofermentative species of lactic acid bacteria that are commonly used in dairy product fermentation and as probiotic cultures. | 200 µg | $980.00 |
| Lactobacillus paracasei Genomic DNA | LBGF-0925-GF922 | Lactobacillus DNA | This product contains high-quality, intact genomic DNA isolated from Lactobacillus paracasei Genomic DNA. It is a purified and ready-to-use DNA sample, ideal for a wide range of molecular biology applications, including PCR, qPCR, and Next-Generation Sequencing. | 5 µg | $720.00 |
| Lactobacillus paracasei subsp. paracasei Genomic DNA | LBGF-0925-GF1506 | Lactobacillus DNA | This product contains high-quality, intact genomic DNA isolated from Lactobacillus paracasei subsp. paracasei Genomic DNA. It is a purified and ready-to-use DNA sample, ideal for a wide range of molecular biology applications, including PCR, qPCR, and Next-Generation Sequencing. | 5 µg | $720.00 |
| Inactivated Lacticaseibacillus paracasei | LBGF-1125-GF9 | Lactobacillus postbiotic | Inactivated Lacticaseibacillus paracasei is a postbiotic raw material. It is a freeze-dried powder composed of beneficial metabolites and cellular components produced by the fermentation and lysis of probiotic microorganisms. | — | Inquiry |
A: We combine 16S rRNA with WGS-based confirmation, then verify phylogenetic placement and contamination status. This resolves close-species ambiguity and supports clean strain traceability for downstream studies.
A: Yes. We run acid/bile survivability screens and adhesion-oriented assays (e.g., mucin or epithelial models). Outputs help prioritize strains that maintain performance after simulated GI stress exposure.
We focus on measurable functional signatures—acidification, antimicrobial activity proxies, antioxidant capacity, and host-response marker panels—so you get interpretable, decision-grade comparisons across strain candidates.
We support genome-informed safety checks and structured strain characterization aligned with widely used assessment logic, helping flag antibiotic resistance or unwanted traits early—before investing heavily in fermentation and formulation.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.